Issued Patents All Time
Showing 1–25 of 29 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12173041 | Cyclin G1 inhibitors and related methods of treating cancer | Erlinda M. Gordon | 2024-12-24 |
| 11325958 | Cyclin G1 inhibitors and related methods of treating cancer | Erlinda M. Gordon | 2022-05-10 |
| 11273206 | Targeting of pharmaceutical agents to pathologic areas using bifunctional fusion polypeptides | Erlinda M. Gordon | 2022-03-15 |
| 10981980 | Polypeptide targeting aptamers for characterization, capture, and clinical management of circulating tumor cells | Erlinda M. Gordon | 2021-04-20 |
| 10913779 | Exposed collagen-targeted fusion cytokine for immune modulation in invasive cancers and lesions of infections | Erlinda M. Gordon | 2021-02-09 |
| 10420820 | Targeting of pharmaceutical agents to pathologic areas using bifunctional fusion polypeptides | Erlinda M. Gordon | 2019-09-24 |
| 9017659 | Pathotropic targeted gene delivery system for cancer and other disorders | Erlinda M. Gordon | 2015-04-28 |
| 8871734 | Transgene delivering retrovirus targeting collagen exposed at site of tissue injury | Erilinda Maria Gordon | 2014-10-28 |
| 8828378 | Targeted vectors for cancer immunotherapy | Erlinda M. Gordon | 2014-09-09 |
| 8530441 | Transgene delivering retrovirus targeting collagen exposed at site of tissue injury | Erlinda M. Gordon | 2013-09-10 |
| 8148509 | Transgene delivering retrovirus targeting collagen exposed at site of tissue injury | Erlinda M. Gordon | 2012-04-03 |
| 8052966 | Methods and compositions for treating metastatic cancer | Erlinda M. Gordon | 2011-11-08 |
| 7820157 | Transgene delivering retrovirus targeting collagen exposed at site of tissue injury | Erlinda M. Gordon | 2010-10-26 |
| 7795023 | Identification of a pluripotent pre-mesenchymal, pre-hematopoietic progenitor cell | Erlinda M. Gordon | 2010-09-14 |
| 7708986 | Targeted vectors for cancer immunotherapy | Erlinda M. Gordon | 2010-05-04 |
| 7605142 | Expression of cyclin G1 in tumors | Erlinda M. Gordon, W. French Anderson | 2009-10-20 |
| 7459541 | Matrix-targeted fusion polypeptides for tissue regeneration and wound healing | Erlinda M. Gordon, Robert W. Beart, Marcel E. Nimni | 2008-12-02 |
| 7347998 | Method of delivering therapeutic agents to site of tissue injury | Erlinda M. Gordon | 2008-03-25 |
| 7078483 | Retroviral vectors including modified envelope escort proteins | Erlinda M. Gordon, W. French Anderson | 2006-07-18 |
| 6955898 | Targeting pharmaceutical agents to injured tissues | Erlinda M. Gordon, Vaughn A. Starnes, W. French Anderson | 2005-10-18 |
| 6864082 | Modified viral surface proteins for binding to extracellular matrix components | Erlinda M. Gordon, W. French Anderson, Vaughn A. Starnes | 2005-03-08 |
| 6844191 | Osteogenic cell growth using a TGFβ1-von Willebrand's factor fusion protein | Erlinda M. Gordon, W. French Anderson | 2005-01-18 |
| 6825033 | Mutated cyclin G1 protein | Erlinda M. Gordon | 2004-11-30 |
| 6410015 | Gene therapy methods using bone marrow-derived cells expressing blood clotting factors | Erlinda M. Gordon, W. French Anderson | 2002-06-25 |
| 6387663 | Targeting pharmaceutical agents to injured tissues | Erlinda M. Gordon, Vaughn A. Starnes, W. French Anderson | 2002-05-14 |